Login / Signup
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Ingo Kleiter
Kerstin Hellwig
Achim Berthele
Tania Kümpfel
Ralf A Linker
Hans-Peter Hartung
Friedemann Paul
Orhan Aktas
null null
Published in:
Archives of neurology (2013)
Keyphrases
</>
multiple sclerosis